Back to Schemes

Sponsored

Urothelial/bladder cancer (FGFR SNV/fusions) [Tissue]

Supported by

Johnson and Johnson

Product Code: 02-FGFR-27

From £796.00

Deadline to order: 28/02/2027

FGFR3 testing (SNVs and gene fusions) in Urothelial / Bladder cancer (FFPE). This EQA is sponsored.

Target/Genes:

FGFR3 variants and fusions

Technology:

NGS, PCR based, rtPCR

Language:

English, French, German, Italian, Spanish

Sample Type:

FFPE

Accredited:

Pending

Sample dispatch to your laboratory:

Jun-27

Test and Submit Results:

June - August 2027

Final Results and Certificate:

December 2027 - January 2028

You can complete purchase on our secure partner site.

How it works

Register

  • Enrol before the closing date (28/02/2027)
  • EMQN ships EQA samples or digital cases

Test & submit results

  • Analyse samples in your routine workflow
  • Upload results via your website account (June - August 2027)

Review & get certified

  • EMQN assesses your data
  • Receive your individual results, EQA summary report & certificate of participation (December 2027 - January 2028)

EQA Assessment

The scheme is designed to assess the analytical process (genotyping), and reporting (biological and clinical interpretation of the test result) including the overall report layout, content and clerical accuracy.

Sample Details

Three mock clinical cases with matching human tumour tissue paraffin embedded (FFPE) and/or artificial FFPE (designed to simulate real patient samples). One 10um or 15um FFPE section per case is provided.

Samples are provided as cut sections (rolled scrolls / curls) only – we cannot provide slide mounted materials. Variant allele frequencies of any artificial FFPE reference materials have been validated using ddPCR.  

EQA Results

Participants will receive an individual report including educational advice and a scheme report which includes additional information from the cohort of participants including geographical spread, methodologies employed, common errors, learning points and scheme statistics allowing participants to benchmark their results.

Each laboratory will also receive a single certificate listing all EQAs participated in with performance result for each year.

Participation Information

Participants are expected to test the samples according to their routine strategy, to return a clinical report and complete a data collection form. Laboratories are expected to provide information about their test scope and the technical and clinical limitations of their assays to enable accurate assessment.

This EQA is supported by an educational grant from Johnson and Johnson, fees are subsidised so there is a reduced cost for participants. EMQN would like to acknowledge and thank Johnson and Johnson for this support. 

Limited to 65 participants, please register early to avoid disappointment. Open to laboratories from ALL countries (note: some restrictions may apply due to sanctions, delivery network exceptions, restrictions on importation etc).

Enquire about this scheme

Contact Information

added wishlist!
View Wishlist

0

View Wishlist

Register Interest

Express your interest in ''.